Market Wrap: May 21, 2026 – Nifty Retreats, But Q4 Stars and

Indian equities experienced a volatile session today, May 21, 2026, with the Nifty retreating from its intraday highs to close in the red amidst rising bond yields and persistent FII selling. The broader Sensex also succumbed to selling pressure, reflecting a cautious sentiment at the top indices. However, Dalal Street presented a tale of divergence, as several large-cap and mid-cap stocks defied the general downturn, showcasing remarkable resilience driven by strong Q4 earnings and specific catalysts. Grasim [GRASIM] was notable among seven large-caps hitting 52-week highs, signalling selective strength within the market.

Analyst sentiment was mixed. While mutual funds signalled caution by trimming exposure to over 15 major stocks in April 2026, some brokerages maintained optimism. Smallcase managers projected the Nifty [NIFTY] could reach 30,000 by FY27, underpinned by robust earnings growth expectations. Conversely, Emkay Global issued a 'Sell' call on Ola Electric, citing weak Q4 performance and increasing competition. Lenskart Solutions, on the other hand, saw brokerage target price upgrades following stellar Q4 results. Jefferies weighed in on India's SIP phenomenon, questioning its potential role in rupee pressure.

Q4 FY24 earnings continued to drive significant stock movements. Financials saw LIC shine, reporting a 23% profit jump to ₹23,467 crore and declaring a ₹10 dividend, while Protean eGov Technologies [PROTEAN] soared 20% on record performance. In the FMCG sector, ITC [ITC] sweetened shareholder returns with an ₹8 final dividend after an impressive 5% profit climb. Consumer & Retail delivered contrasting stories: Nykaa's [NYKAA] profit surged 286% on a 28% revenue jump, but Jubilant Foodworks [JUBLFOOD] shares plunged post-Q4 due to investor concerns. Cement stocks gained attention with JSW Cement [JSWCEMENT] reporting a monumental Q4 profit surge and a ₹0.5 dividend. Pharma major Sun Pharma is poised for strong Q4FY26 results, with speciality drugs in focus. In a significant market development, NCDEX launched India's first Weather Futures, offering a new tool for monsoon risk management. Midcap marvels continued to rally, with some Indian stocks gaining up to 51% amidst global uncertainties. Apollo Micro Systems [APOLLO] also soared post-Q4 FY24, attracting a 'BUY' recommendation.

Investors will continue to monitor FII flows and bond yield movements. The upcoming ET Alpha Wealth Summit, set to tackle themes like AI, geopolitics, and oil, could provide fresh cues. With more Q4 results anticipated, including Sun Pharma, selective stock-picking based on fundamental strength and earnings visibility will likely remain the guiding principle.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Stock market investments are subject to market risks. Please consult your financial advisor before making any investment decisions. StockTips.in is not a SEBI-registered investment advisor.